Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
Journal: Leukemia & lymphoma
Published: January 05, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.
Journal: Blood
Published: December 24, 2024
The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era.
Journal: Seminars in hematology
Published: May 07, 2024
KLRG1, Another Opportunity for a Breakthrough in MTCL.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2024
Approach to High-Risk Multiple Myeloma.
Journal: Hematology/oncology clinics of North America
Published: January 09, 2024
On the Precipice of a "Rituximab-Like" Era for T-Cell Lymphomas?
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2023
Novel agents in relapsed/refractory diffuse large B-cell lymphoma.
Journal: Hematological oncology
Published: March 28, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 24, 2022
Polatuzumab vedotin in relapsed / refractory aggressive B-cell lymphoma.
Journal: Expert review of anticancer therapy
Published: June 21, 2022
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Journal: Blood advances
Published: February 08, 2021
Last Updated: 09/26/2026